In lieu of an abstract, here is a brief excerpt of the content:

Contributors tamar barlam, m.d. received her degree from the University of Rochester School of Medicine and received her infectious disease training at the Columbia-Presbyterian Medical Center. She served on the infectious disease faculty at St. Luke’s–Roosevelt Hospital Center in New York and the Beth Israel Deaconess Medical Center in Boston. In addition , she was an assistant clinical professor in medicine at the Columbia College of Physicians and Surgeons and assistant professor of medicine at the Harvard Medical School. She has a long-standing interest in the appropriate use of antibiotic drugs and in 2000 joined the Center for Science in the Public Interest in Washington, D.C., to direct the Project on Antibiotic Resistance. Currently, she is on the infectious disease faculty at the Boston Medical Center and the Veterans Administration Boston Healthcare System and serves as associate professor of medicine at the Boston University School of Medicine. paul r. billings, m.d., ph.d., is an internist and medical geneticist who is also an adjunct professor of anthropology at the University of California , Berkeley. He chairs the Council for Responsible Genetics and is vice president and national director for genetics and genomics at Laboratory Corporation of America Holdings. berkeley biotechnology working group members share and critique research on the ecological, economic, political, social, and ethical contexts and effects of biotechnology. Along with Paul R. Billings, Richard C. Strohman, and Kenneth A. Worthy, contributing authors to 327 this chapter include Jason A. Delborne, a doctoral candidate at the University of California, Berkeley, who is researching the management of scienti fic dissent in agricultural biotechnology; Earth Duarte-Trattner, also at Berkeley, where he is completing his dissertation, “From Slaves to Transgenic Organisms: A History of Branding in Mexico and California”; Nathan Gove, who holds a master’s in environmental science, policy, and management from Berkeley and currently works at the Biological Resources Research Center, University of Nevada, Reno; Daniel R. Latham, a doctoral candidate at Berkeley who is researching the biological control of insect pests in organic fruit orchards; and Carol J. Manahan, a student at the Graduate Theological Union, Berkeley, who is writing her dissertation , entitled, “The Moral Economy of Corn: StarLink and the Ethics of Resistance.” Delborne and Manahan founded the group in 2001, inspired by conversations with Professor Charles Weiner. david l. demets is professor and chair of the Department of Biostatistics and Medical Informatics at the University of Wisconsin–Madison. He received his doctoral degree in 1970 from the University of Minnesota, spent twelve years at the National Institutes of Health, and has been at the University of Wisconsin since 1982. DeMets is a recognized international leader in statistical research and methods for the analysis of clinical trials. He has coauthored nearly two hundred papers and book chapters, as well as two books, Fundamentals of Clinical Trials and Data Monitoring Committees in Clinical Trials: A Practical Perspective. paul gepts is professor in the Department of Agronomy and Range Science at the University of California, Davis. His research focuses on the study of evolutionary and molecular mechanisms responsible for crop biodiversity , including the process of domestication, with emphasis on Phaseolus beans and the cowpea. He has conducted fieldwork in Latin America and Africa, as well as laboratory work in the United States. He is a Fellow of the American Association for the Advancement of Science (2001) and the American Society of Agronomy (2003). lawrence gostin is professor of law at Georgetown University; professor of Public Health at the Johns Hopkins University; and director of the Center for Law & the Public’s Health at Johns Hopkins and Georgetown Universities (CDC Collaborating Center “Promoting Public Health 328 Contributors [3.144.212.145] Project MUSE (2024-04-24 20:04 GMT) through Law”; http://www.publichealthlaw.net). He is a research fellow at the Centre for Socio-Legal Studies, Oxford University. Professor Gostin has led major law reform initiatives for the U.S. government, including the Model State Emergency Health Powers Act (MSEHPA) to combat bioterrorism and other emerging health threats. Gostin’s latest books are The AIDS Pandemic: Complacency Injustice, and Unfulfilled Expectations (2004); The Human Rights of Persons with Intellectual Disabilities: Different But Equal (2003); Public Health Law and Ethics: A Reader (2002); Pubic Health Law: Power, Duty, Restraint (2000). jo handelsman is Howard Hughes Medical Institute Professor in the Department of Plant Pathology and codirector of the Women in Science and Engineering Leadership Institute at the University of Wisconsin– Madison. Her work has appeared...

Share